What Kymera Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 9 | 277 |
| Total trades | 10 | 329 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 30,000 | 2,880,370 |
| Disposed | 36,371 | 2,959,868 |
| Net activity | −6,371 | −79,498 |
Common stock only — 4 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −262 | $116.12 | −$30.4K | 666,568 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −8,230 | $115.40 | −$950K | 666,830 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −7,601 | $114.43 | −$870K | 675,060 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −4,876 | $113.24 | −$552K | 682,661 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −5,506 | $112.42 | −$619K | 687,537 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Open-market sale · S | −3,525 | $111.44 | −$393K | 693,043 |
| Mainolfi Nello | Chief Executive Officer | Oct 01 | Exercise / conversion · M | +30,000 | $2.08 | +$62.4K | 696,568 |
| Adams Brian | Chief Legal Officer | Sep 04 | Open-market sale · S | −2,137 | $117.57 | −$251K | 50,254 |
| Adams Brian | Chief Legal Officer | Sep 04 | Open-market sale · S | −3,025 | $116.81 | −$353K | 52,391 |
| Adams Brian | Chief Legal Officer | Sep 04 | Open-market sale · S | −1,209 | $115.55 | −$140K | 55,416 |
| Rooney Terence | Chief Medical Officer | Jul 27 | Grant / award · A | +38,000 | — | — | 38,000 |
| Mainolfi Nello | Chief Executive Officer | Jul 07 | Open-market sale · S | −50,000 | $119.00 | −$5.95M | 666,568 |
| Mainolfi Nello | Chief Executive Officer | Jul 07 | Exercise / conversion · M | +50,000 | $2.08 | +$104K | 716,568 |
| Goodman Noah | Chief Business Officer | Jul 01 | Open-market sale · S | −3,389 | $114.29 | −$387K | 47,179 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Open-market sale · S | −3,336 | $116.56 | −$389K | 666,568 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Open-market sale · S | −44,050 | $115.69 | −$5.1M | 669,904 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Open-market sale · S | −24,105 | $114.96 | −$2.77M | 713,954 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Open-market sale · S | −6,626 | $113.98 | −$755K | 738,059 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Open-market sale · S | −1,883 | $112.80 | −$212K | 744,685 |
| Mainolfi Nello | Chief Executive Officer | Jul 01 | Exercise / conversion · M | +80,000 | $2.08 | +$166K | 746,568 |
Loading...
